Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $12.6700 (-0.08%) ($12.3000 - $12.8400) on Mon. Jun. 5, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.83% (three month average) | RSI | 34 | Latest Price | $12.6700(-0.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.4% a day on average for past five trading days. | Weekly Trend | HALO declines -5.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(52%) IWM(49%) ARKG(48%) | Factors Impacting HALO price | HALO will decline at least -1.415% in a week (0% probabilities). VIXM(-13%) UUP(-10%) TLT(-6%) SHY(-3%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.415% (StdDev 2.83%) | Hourly BBV | 0 () | Intraday Trend | -1.3% | | | |
|
1 - 5 Day Possible Target | $0.79(-93.76%) | Resistance Level | $13.16 | 5 Day Moving Average | $12.31(2.92%) | 10 Day Moving Average | $12.49(1.44%) | 20 Day Moving Average | $13.16(-3.72%) | To recent high | -13.7% | To recent low | 7.4% | Market Cap | $1.732b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |